tak 779 has been researched along with raltegravir in 1 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (raltegravir) | Trials (raltegravir) | Recent Studies (post-2010) (raltegravir) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 100 | 9 | 73 |
| Protein | Taxonomy | tak 779 (IC50) | raltegravir (IC50) |
|---|---|---|---|
| Gag-Pol polyprotein | HIV-1 M:B_HXB2R | 0.015 | |
| Integrase | Human immunodeficiency virus 1 | 0.1953 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horuk, R; Pease, J | 1 |
1 other study(ies) available for tak 779 and raltegravir
| Article | Year |
|---|---|
Chemokine receptor antagonists.
Topics: Animals; Autoimmune Diseases; Humans; Receptors, Chemokine | 2012 |